Riskpilot← Back to searchSign inGet full accessEbba HVB AB
ABActiveOrg 5591577191AnebyMedical specialists activities · NACE 8622Est. 201818 employees
Revenue 2025
SEK 18,5M
+10% vs 2024
EBITDA margin
7.5%
+16% vs 2024
Equity ratio
38.0%
Financial strength
Net profit 2025
SEK 72K
+154% vs 2024
| Revenue | SEK 18,5M | +10% |
| EBITDA | SEK 1,4M | +16% |
| Net profit | SEK 72K | +154% |
| Total assets | SEK 3,2M | -6% |
| Equity | SEK 1,2M | +6% |
| Employees | 18 | — |
Legal name
Ebba HVB AB
Org number
5591577191
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
2 maj 2018
Share capital
SEK 50 000
Employees
18 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-04-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamöterna
Company purpose
Bolaget skall bedriva vård och behandling inom psykiatri, missbruk, utredning och därmed förenlig verksamhet.
Address
Aneby
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1 549 | 13 842 | 19 439 | 17 903 | 16 878 | 18 530 |
| Staff expenses | — | — | — | — | — | −10 019 | −10 952 |
| EBITDA | −139 | −1 126 | 119 | 1 156 | −68 | 1 185 | 1 381 |
| Depreciation & amort. | −0 | −14 | −64 | −60 | −60 | −60 | −55 |
| EBIT | −139 | −1 140 | 55 | 1 096 | −128 | 1 125 | 1 325 |
| Net financials | — | −16 | −46 | −29 | −17 | −11 | −9 |
| Profit before tax | −4 | −392 | 464 | 782 | 26 | 65 | 116 |
| Tax | −0 | −0 | −16 | −177 | −22 | −36 | −43 |
| Net profit | −4 | −392 | 448 | 605 | 4 | 29 | 72 |
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Total assets | 46 | 1 355 | 2 737 | 3 811 | 3 266 | 3 378 | 3 168 |
| Equity | 46 | 46 | 494 | 1 098 | 1 102 | 1 131 | 1 203 |
| Long-term debt | 0 | 725 | 444 | 30 | 0 | — | — |
| Short-term debt | 0 | 584 | 1 780 | 2 378 | 1 859 | 1 943 | 1 965 |
| Total debt | — | 1 309 | 2 224 | 2 408 | 1 859 | 1 943 | 1 965 |
EBITDA margin
7.5%
This company
15.8%
Market median
-53% vs market
20192025
Equity ratio
38.0%
This company
38.2%
Market median
+1% vs market
20192025
Return on equity
6.0%
This company
18.4%
Market median
-67% vs market
20192025
Net profit margin
0.4%
This company
8.1%
Market median
-95% vs market
20192025
Asset turnover
5.85×
This company
1.12×
Market median
+422% vs market
20192025
Debt / equity
1.63×
This company
0.62×
Market median
-163% vs market
20192025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-05-01 – 2025-04-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-05-01 – 2024-04-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-05-01 – 2023-04-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-05-01 – 2022-04-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-05-01 – 2021-04-30
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-05-01 – 2020-04-30
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-05-01 – 2019-04-30
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
SC Chief Executive Officer | Chief Executive Officer | 2020 | — | — |
DE | Audit | 2020 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2020 | — | — | |
| Deputy Board Member | 2022 | — | — | |
| Chairman | 2020 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Läkemedelsgruppen Aneby Invest AB | Company | 100.0% | 100.0% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Läkemedelsgruppen Aneby Invest AB
Ebba HVB AB Board members of Ebba HVB AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Susanne Charlotte Ulrika Petersson | Chief Executive Officer | 0 companies |
| Didric Eric Andersson | Audit | 0 companies |
| Carl Johan Hjertberg | Board of Directors | 0 companies |
| Hans Christer Hagström | Deputy Board Member | 0 companies |
| Emil Staffan Mattias Rosenberg | Chairman | 0 companies |